# FDA Inspection 1177256 - Regenerative Biologics Inc. - August 01, 2022

Source: https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/8e729ede-cf09-498e-bb27-21f1f00bf3ec
Source feed: FDA_Inspections

> FDA Inspection 1177256 for Regenerative Biologics Inc. on August 01, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1177256
- Company Name: Regenerative Biologics Inc.
- Inspection Date: 2022-08-01
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1177256 - 2022-08-01](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/c2b56ed2-59ed-4315-8ba8-2c32caa50740)
- [FDA Inspection 1177256 - 2022-08-01](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/3fad58ec-17fe-4687-a4ca-f28512a3edbb)

Company: https://www.keypedia.com/companies/regenerative-biologics-inc/2d94f15c-c6d1-43dd-a00b-5c93dc4f3330

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d